Loading...
News Volatility EA (MT5) — review, price and free alternatives
MT5 expert advisor$1000 on MQL5by Kelvin Azibator Rex Ogbuku
News Volatility EA is a MetaTrader 5 expert advisor by Kelvin Azibator Rex Ogbuku, sold on the MQL5 Market for $1000. It can't be downloaded here: buy it, or try its free demo, on its MQL5 page. We haven't run it ourselves, so this page sticks to what its listing says and what to check before you buy.
News Volatility EA — key facts
- Platform
- MetaTrader 5 (MT5)
- Product type
- Expert advisor
- Developer
- Kelvin Azibator Rex Ogbuku
- Price
- $1000
- Listing
- MQL5 Market (mql5.com)
- FxRobotEasy verification status
- FxRobotEasy has not traded News Volatility EA on a live account and publishes no broker-verified performance record for it.
Last updated
What the developer says
This Expert Advisor is designed for traders who want to participate in periods of strong market volatility and rapid price expansion.
Before you buy News Volatility EA
What the developer claims
- It also includes automated trade and risk management so that positions can be managed after entry without requiring constant manual intervention.
Quoted from the listing. We have not tested these claims.
What to check first
- A live track record. Ask for an MQL5 signal on a real account, ideally three months or longer. Back-tests and screenshots are not a track record.
- The free demo first. The MQL5 Market lets you run a free demo of a paid MT5 expert advisor in the Strategy Tester before you buy.
- Risk controls. Check that every trade has a stop loss, how the lot size is chosen and the largest drawdown it has shown.
- Broker conditions. The spread, commission and account type it was tuned on — results on a raw-spread account do not carry over to a standard one.
- Updates and support. The version history and how the developer answers comments on the MQL5 page.
Editorial notes on News Volatility EA
Compiled from its public MQL5 listing. FxRobotEasy has not traded News Volatility EA; what these notes say about how it works comes from that listing.
Overview
This comprehensive 2026 News Volatility EA review examines real performance and trading analysis to help you make informed decisions. News Volatility EA by Kelvin Azibator Rex Ogbuku represents a comprehensive automated trading solution for MT5 traders. What sets News Volatility EA apart is its balanced approach to trade execution and capital preservation.
Risk notes
News Volatility EA implements a moderate risk profile with configurable parameters for different trading styles. The system uses stop losses on all positions and employs dynamic position sizing based on account equity. Recommended minimum account size ensures proper risk distribution.
Listed strengths
- MT5 platform compatibility
- Developed by experienced Kelvin Azibator Rex Ogbuku
- Includes risk management features
Worth checking
- Requires adequate account capital
- Not suitable for all market conditions
- Needs proper configuration
Setup
Installing News Volatility EA on MT5 requires copying the EA file to your platform's Experts directory. After restart, attach to appropriate charts and configure risk parameters. Always backtest with historical data before live deployment.
Free to try · from FxRobotEasy
Looking for a breakout robot you can try free?
Our robots at work. Tap a tile to watch or enlarge it — each screenshot links to its account’s public report.
Breakopedia AIby FxRobotEasy
Our breakout robot — entries confirmed by pivot structure
- Get the installer on a Windows PCNo sign-up to download. On a phone, send yourself the link.
- Run it and sign in inside the appGoogle, Telegram or e-mail — about 10 minutes in all.
- Pick Breakopedia AIIt starts on a free demo account: virtual money, every trade visible.
FxRobotEasy on Telegram
The team's notes, every day
- What we ship, what breaks and how we fix it
- Breakopedia AI in our bot — set up from your phone, run it on a Windows PC
- Questions answered in the bot
News Volatility EA or Breakopedia AI?
| News Volatility EA | Breakopedia AI | |
|---|---|---|
| How you get it | Buy on MQL5 ($1000) | Free installer; runs on a demo account first |
| Platform | MT5 | MT5 |
| Public account reports | — | Yes — see the screenshots above |
| Made by | Kelvin Azibator Rex Ogbuku | FxRobotEasy |
News Volatility EA — questions
What is News Volatility EA?
News Volatility EA is a MetaTrader 5 Expert Advisor (trading robot) published on the MQL5 Market by Kelvin Azibator Rex Ogbuku, priced at $1,000 USD. As an Expert Advisor it can open and manage positions on its own once it is attached to a chart and algorithmic trading is enabled in the terminal.
Does News Volatility EA work on MT4 or MT5?
News Volatility EA runs on MetaTrader 5, not MetaTrader 4. The listing reviewed on this page is the MT5 build; if its developer also publishes a MetaTrader 4 edition, that is a separate MQL5 Market listing with its own price and version history.
How much does News Volatility EA cost?
News Volatility EA is a paid product listed at $1,000 USD on the MQL5 Market, the price recorded when its listing was last checked on 2026-09-09. It is sold and downloaded through the developer's (Kelvin Azibator Rex Ogbuku) page on mql5.com; FxRobotEasy neither sells it nor hosts the file.
Is there a verified track record for News Volatility EA?
FxRobotEasy has not traded News Volatility EA on a live account, so no independently verified track record for it is published here. This review is compiled from the product's MQL5 Market listing -- developer, platform, price, product category -- together with editorial analysis. Any back-tested or simulated figures shown alongside it are simulations rather than live trading results, and any performance claim you find for News Volatility EA elsewhere comes from its developer or from a third party.
Similar expert advisors
Product data from the MQL5 marketplace. Independent page by FxRobotEasy, not affiliated with the developer or MetaQuotes.
Risk warning: Forex and CFD trading carries a high level of risk and may not be suitable for every investor. Past performance is not indicative of future results. Read our risk warning and review methodology.